An interventional study of Mirror Therapy and Regular Rehabilitation in Stroke, Acute, sponsored by Health Sciences North Research Institute. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Health Sciences North Research Institute · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 444 studies in Stroke with a site in Canada — 83 open to participants now, 99 under way, 13 of them phase 3. Stroke · Canada.
Among the 444 studies in Stroke with a site in Canada, this one is the 306th largest by enrollment of the 374 interventional ones that give a count, is one of 24 that started in 2022, is one of 224 with no phase, and was the 322nd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →83 of the 444 studies in Stroke with a site in Canada are open now. Recruiting first, the newest first:
Sunnybrook Health Sciences Centre · Sites in Canada
Ages 75+
Population Health Research Institute · Sites in Canada
Ages 18+
McMaster University · Sites in Canada
University of Calgary · Sites in Canada, Australia
Ages 18+
Regeneron Pharmaceuticals · Sites in Canada, United States, Japan
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
444 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 48 · Phase 3 78 · Phase 4 25
First in 1998; this study’s year is marked. 24 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 74 across the 374 interventional studies, 150 across the 67 observational. Of the 282 that completed or were terminated, 63 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
88 of 444 have an industry lead sponsor. The 10 most frequent:
Health Sciences North Research Institute is the lead sponsor of 10 studies on the registry; none are open to participants now.
Health Sciences North Research Institute has 1 study filed under Stroke — fewer than ten, so there is no comparison to draw.
35 of the studies in Stroke with a site in Canada that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05065216Phase 3DiaMedica Therapeutics IncTreatment of Acute Ischemic Stroke (ReMEDy2 Trial) | 2026-12 |
| NCT06296082Phase 3Universiteit AntwerpenComparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity | 2026-12-30 |
| NCT07201974McGill UniversityVirtual Reality for Post-Stroke Gait Rehabilitation | 2026-11 |
| NCT05595668Nova Scotia Health AuthorityEngaging Mobile Prism Adaptation Treatment at Home | 2026-11 |
| NCT06828653Holland Bloorview Kids Rehabilitation HospitalComparing Digitally and Traditionally Made Ankle Foot Orthoses | 2026-12 |
Add all 35 to your calendar (.ics) → With an account.
Among the 444 studies in Stroke with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In Canada, the number of stroke survivors is equivalent to the size of one of the four Atlantic Provinces. The incident rate of stroke has been increasing steadily since 1995. The majority of the stroke survivors lose upper extremity function, resulting in diminished activities of daily living (ADL). Many therapeutic interventions are recommended to improve upper extremity function or ADLs of stroke survivors, however, Mirror Therapy (MT), inexpensive intervention, can be self-administered by stroke survivors with intact cognition. Thus, the research question is whether a self-administered MT technique improves acute stroke patients' upper extremity motor function and recovery?
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this group will receive standard of care based on their needs along with mirror therapy education.
Other: Mirror Therapy · Other: Regular Rehabilitation
Participants in this group will receive only standard of care based on their needs.
Other: Regular Rehabilitation
Participants will receive the standard-of-care; multidisciplinary rehabilitation intervention based on their needs and tolerance, and will receive an additional 30 min of Mirror Therapy education. During Mirror Therapy education, the patients will be educated or shown how to perform MT and the patients will complete the recommended exercises on their own for 30 minutes/day for 5 days a week/ for 4 weeks. Standard Mirror Therapy Protocol will be followed.
Participants will receive the standard-of-care, multidisciplinary rehabilitation intervention based on their needs and tolerance.
Fugl-Meyer Assessment scale
Scores of \< 31 corresponded with 'no to poor' upper extremity capacity, 32 to 47 represented 'limited capacity', 48 to 52 represented 'notable capacity' and 53 to 66 represented 'full' upper extremity capacity.
Time frame: Assessment will be completed at 2 points: Pre-test assessment will be done within 48 hours of stroke admission and post-test assessment will be done at 4 weeks.
Wolf Motor Function Test
Assess upper extremity function; maximum Score is 75; lower scores are indicative of lower functional levels.
Time frame: : Assessment will be completed at 2 points: Pre-test assessment will be done within 48 hours of stroke admission and post-test assessment will be done at 4 weeks
Modified Barthel Index
Assess Activity of Daily Living, Scores of \<15 usually represents moderate disability and \<10 usually represents severe disability.
Time frame: : Assessment will be completed at 2 points: Pre-test assessment will be done within 48 hours of stroke admission and post-test assessment will be done at 4 weeks
Ran from Jul 2022 to primary completion in May 2024, 21 months.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 21 months is close to that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 5, 2026: start May 2021 → Jul 2022, primary completion Sep 2021 → May 2024 and completion Sep 2021 → May 2024.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Health Sciences North Research Institute